GNH USA

Europe — EMA

Minrin (Desmopressin Acetate)

GNH USA supplies Minrin (Desmopressin Acetate), a antidiuretic hormone analog for central diabetes insipidus, nocturnal enuresis and hemophilia A bleeding

Request sourcing

1
Pack/s

What is Desmopressin Acetate?

Desmopressin Acetate, the active ingredient in Minrin, is an antidiuretic hormone analog presented as an oral formulation for systemic use. It is employed to manage conditions such as central diabetes insipidus, nocturnal enuresis, and bleeding episodes in hemophilia A.

GNH USA supplies Minrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Desmopressin Acetate used for?

Desmopressin acetate acts on the antidiuretic pathway to restore water balance and reduce bleeding. - Central diabetes insipidus: increases renal water reabsorption to control excessive urine output. - Nocturnal enuresis: reduces nighttime urine production, helping children achieve dry nights. - Hemophilia A (bleeding episodes): raises plasma factor VIII levels to aid hemostasis during minor bleeds.

What are the side effects of Desmopressin Acetate?

Desmopressin acetate may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional, often transient. - Hyponatremia: mild reduction in serum sodium. - Abdominal cramps: intermittent discomfort. - Flushing: transient reddening of skin.

Serious or Rare Side Effects: - Severe hyponatremia: can lead to neurological symptoms. - Seizures: associated with profound electrolyte disturbance. - Water intoxication: excessive fluid retention. - Allergic reactions: rash, pruritus, or angioedema. - Thrombotic events: rare clot formation in predisposed patients.

What precautions apply to Desmopressin Acetate?

Before initiating therapy, clinicians should evaluate individual risk factors and monitor relevant parameters. - Monitor serum sodium: check levels regularly, especially during the first weeks of treatment. - Adjust dose in renal impairment: reduce dosage or increase monitoring frequency. - Use caution in the elderly: heightened susceptibility to hyponatremia. - Avoid concomitant use with other antidiuretics: increased risk of water overload. - Assess fluid intake: advise patients to limit excessive water consumption. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

What does Desmopressin Acetate interact with?

Desmopressin acetate can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: may potentiate antidiuretic effect and hyponatremia. - Carbamazepine: induces hepatic metabolism, reducing desmopressin levels. - Loop diuretics: increase risk of electrolyte imbalance.

Moderate Interactions (Monitor Closely): - NSAIDs: can blunt renal response to desmopressin. - ACE inhibitors: may enhance sodium loss. - SSRIs: additive effect on serum sodium. - Antihypertensives: monitor blood pressure changes. - Alcohol: can exacerbate fluid retention and hyponatremia.

Frequently asked questions

What conditions is Minrin used to treat?+
Minrin contains desmopressin acetate and is prescribed for central diabetes insipidus to reduce excessive urine output, for nocturnal enuresis in children to lessen nighttime bedwetting, and for hemophilia A bleeding episodes to modestly raise factor VIII levels and support clot formation.
How does desmopressin acetate work in the body?+
Desmopressin acetate mimics the natural hormone vasopressin and selectively activates V2 receptors in the kidney’s collecting ducts. This triggers a cascade that inserts aquaporin‑2 channels into the duct lining, allowing more water to be reabsorbed and concentrating urine. In hemophilia A, it prompts endothelial cells to release stored factor VIII, modestly increasing clotting activity.
What is the usual dose of Minrin?+
The appropriate dose of Minrin is determined by the prescribing clinician based on the patient’s age, weight, renal function, and specific indication. Dosage may vary widely, and the prescriber will tailor the regimen to achieve the desired therapeutic effect while minimizing risk.
Is Minrin safe to use during pregnancy or breastfeeding?+
Safety data for desmopressin acetate in pregnancy and lactation are limited. Clinicians should weigh potential benefits against possible risks and consider alternative therapies when possible. If treatment is deemed necessary, it should be prescribed at the lowest effective dose and under close medical supervision.
How do I order Minrin from GNH USA?+
To request Minrin, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Minrin compare with other antidiuretic agents?+
Minrin (desmopressin acetate) is a selective V2‑receptor agonist, offering a more targeted antidiuretic effect than non‑selective vasopressin analogues. It has a longer half‑life and fewer vasoconstrictive side effects, making it preferable for chronic management of diabetes insipidus and nocturnal enuresis. However, clinicians must still monitor for hyponatremia, a risk shared with other antidiuretic drugs.
What are the recommended storage conditions for Minrin?+
Minrin should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Do not store in a bathroom or near heat sources, and keep the container tightly closed when not in use.
How is Minrin administered to patients?+
Minrin is taken orally, usually as a tablet or oral melt, according to the prescriber’s instructions. It should be swallowed with a glass of water, and the timing of doses may be coordinated with meals or bedtime depending on the indication and patient’s routine.
What are the most serious risks associated with Minrin?+
The most serious risks include severe hyponatremia, which can lead to seizures, cerebral edema, or coma, and water intoxication from excessive fluid retention. Patients should be educated to monitor fluid intake and report symptoms such as headache, nausea, confusion, or sudden weight gain promptly.
Who should not use Minrin?+
Minrin is contraindicated in patients with known hypersensitivity to desmopressin acetate, uncontrolled hyponatremia, or severe renal impairment. Caution is also advised for individuals taking other antidiuretic agents, certain diuretics, or medications that affect sodium balance, as they may increase the risk of adverse electrolyte disturbances.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Desmopressin Acetate
Route
Oral Use
Manufacturer
Ferring B.V.
Origin
EU

Related products